• Allth Genetic Polymorphism

    Allth Genetic Polymorphism

    Hoʻohanaʻia kēia pahu no kaʻike vitro qualitaitive o ka aldh2 gy gy g1510a polymorphim o ke kino genomic

  • Kanaka cyp2c9 a me V VIWC1 WYCOM1 WYCOMORPHIMS

    Kanaka cyp2c9 a me V VIWC1 WYCOM1 WYCOMORPHIMS

    Ua pili kēia kī i ka citro cittistative i keʻano o ka polymorphism o cyp2c9 * 3 Rs1057910, -16394, 6759

  • Kanaka cyp2c19 wahine polymorphom

    Kanaka cyp2c19 wahine polymorphom

    Ua hoʻohanaʻia kēia pahu no kaʻike vitro qualitaitive o ka polymorphism o cyp2c19 * 2 (Rs12985, C.85, C.806 > T) ma Genomic DNA o ke koko holoʻokoʻa mau hiʻohiʻona.

  • Aliʻi lekoicyte antigen b27 nuklec AcID

    Aliʻi lekoicyte antigen b27 nuklec AcID

    Hoʻohanaʻia kēia pahu no kaʻike muaʻana o ka DNA i ka DNA i keʻano o ke kanaka lekia-b * 2704 a me HLA-B * 2705.

  • Mthfr ge ge ge gedomorphic nule

    Mthfr ge ge ge gedomorphic nule

    Hoʻohanaʻia kēia kī eʻike i nā pūnaewele 2 o nā pūnaewele mtfr Gene. Hoʻohana ka pahu i ke koko holoʻokoʻa ma keʻano he hōʻike hōʻike hōʻike e hāʻawi i kahi loiloi centetivative e hāʻawi i ke kūlana o ke kūlana mutation. Hiki iā ia ke kōkua i nā clinicions e hoʻolālā i nā hoʻolālā hoʻolālā kūpono no nāʻano likeʻole o nā mea maʻi i ka nui o nā maʻi.